Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital H

ch as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are part of the disease follow-up, where a monitors medicine concentration.

The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (su